Splenic marginal zone lymphoma natural history, complications and prognosis: Difference between revisions
No edit summary |
No edit summary |
||
| Line 3: | Line 3: | ||
{{CMG}}, {{AE}} {{AS}} | {{CMG}}, {{AE}} {{AS}} | ||
==Overview== | ==Overview== | ||
[Hemoglobin]] level of less than 12 g/dL, [[lactate dehydrogenase]] level higher than normal, blood serum [[albumin]] levels of less than 3.5 g/dL, and some genetic mutations, such as mutations in ''NOTCH2' are 'associated with a particularly poor prognosis among patients with splenic marginal zone lymphoma. | |||
==Prognosis== | ==Prognosis== | ||
* Poor prognosis<ref name="Arcaini2006">{{cite journal|last=Arcaini|first=L.|year=2006|title=Splenic marginal zone lymphoma: a prognostic model for clinical use|journal=Blood|volume=107|issue=12|pages=4643–4649|issn=0006-4971|doi=10.1182/blood-2005-11-4659}}</ref> | |||
:* [[Hemoglobin]] level of less than 12 g/dL | :* [[Hemoglobin]] level of less than 12 g/dL | ||
:* [[Lactate dehydrogenase]] level higher than normal | :* [[Lactate dehydrogenase]] level higher than normal | ||
Revision as of 16:45, 14 January 2016
|
Splenic marginal zone lymphoma Microchapters |
|
Differentiating Splenic marginal zone lymphoma from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Splenic marginal zone lymphoma natural history, complications and prognosis On the Web |
|
American Roentgen Ray Society Images of Splenic marginal zone lymphoma natural history, complications and prognosis |
|
FDA on Splenic marginal zone lymphoma natural history, complications and prognosis |
|
CDC on Splenic marginal zone lymphoma natural history, complications and prognosis |
|
Splenic marginal zone lymphoma natural history, complications and prognosis in the news |
|
Blogs on Splenic marginal zone lymphoma natural history, complications and prognosis |
|
Directions to Hospitals Treating Splenic marginal zone lymphoma |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1], Associate Editor(s)-in-Chief: Sowminya Arikapudi, M.B,B.S. [2]
Overview
[Hemoglobin]] level of less than 12 g/dL, lactate dehydrogenase level higher than normal, blood serum albumin levels of less than 3.5 g/dL, and some genetic mutations, such as mutations in NOTCH2' are 'associated with a particularly poor prognosis among patients with splenic marginal zone lymphoma.
Prognosis
- Poor prognosis[1]
- Hemoglobin level of less than 12 g/dL
- Lactate dehydrogenase level higher than normal
- Blood serum albumin levels of less than 3.5 g/dL
- Some genetic mutations, such as mutations in NOTCH2, are also correlated with shorter survival
References
- ↑ Arcaini, L. (2006). "Splenic marginal zone lymphoma: a prognostic model for clinical use". Blood. 107 (12): 4643–4649. doi:10.1182/blood-2005-11-4659. ISSN 0006-4971.